Year: 2015
Type: article
Abstract: // Ok-Seon Kwon 1 , Ensel Oh 2 , Jeong-Rak Park 1 , Ji-Seon Lee 1 , Gab-Yong Bae 1 , Jae-Hyung Koo 3 , Hyongbum Kim 4 , Yoon-La Choi 5 , Young Soo Choi 6 , Jhingook Kim 6 , Hyuk-Jin Cha 1 1 College of Natural Sciences, Department of Life Sciences, Sogang University, Seoul, Republic of Korea 2 Laboratory of Cancer Genomics and Molecular Pathology, Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Republic of Korea 3 Department of Brain and Cognitive Sciences, DGIST Daegyu, Republic of Korea 4 Department of Pharmacology, Yonsei University College of Medicine, Seoul 5 Department of Pathology, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea 6 Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea Correspondence to: Hyuk-Jin Cha, e-mail: [email protected] Jhingook Kim, e-mail: [email protected] Keywords: metastasis, GalNAc-T14, WNT/TCF pathway, HOXB9, invasion Received: July 30, 2015 Accepted: October 15, 2015 Published: October 26, 2015 ABSTRACT While metastasis, the main cause of lung cancer-related death, has been extensively studied, the underlying molecular mechanism remains unclear. A previous clinicogenomic study revealed that expression of N-acetylgalactosaminyltransferase (GalNAc-T14), is highly inversely correlated with recurrence-free survival in those with non-small cell lung cancer (NSCLC). However, the underlying molecular mechanism(s) has not been determined. Here, we showed that GalNAc-T14 expression was positively associated with the invasive phenotype. Microarray and biochemical analyses revealed that HOXB9 , the expression of which was increased in a GalNAc-T14-dependent manner, played an important role in metastasis. GalNAc-T14 increased the sensitivity of the WNT response and increased the stability of the β-catenin protein, leading to induced expression of HOXB9 and acquisition of an invasive phenotype. Pharmacological inhibition of β-catenin in GalNAc-T14-expressing cancer cells suppressed HOXB9 expression and invasion. A meta-analysis of clinical genomics data revealed that expression of GalNAc-T14 or HOXB9 was strongly correlated with reduced recurrence-free survival and increased hazard risk, suggesting that targeting β-catenin within the GalNAc-T14/WNT/ HOXB9 axis may be a novel therapeutic approach to inhibit metastasis in NSCLC.
Source: Oncotarget
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: diamond
Awards: G1640188266, G2896287762, G7319196040
OpenAlex ID: W2170205697
